Standout Papers

Idelalisib, an inhibitor of phosphatidylinositol 3-kinase p110δ, for relapsed/refractory chronic ly... 2014 2026 2018 2022 462
  1. Idelalisib, an inhibitor of phosphatidylinositol 3-kinase p110δ, for relapsed/refractory chronic lymphocytic leukemia (2014)
    Jennifer R. Brown, John C. Byrd et al. Blood

Immediate Impact

2 by Nobel laureates 18 from Science/Nature 59 standout
Sub-graph 1 of 20

Citing Papers

JAK inhibition enhances checkpoint blockade immunotherapy in patients with Hodgkin lymphoma
2024 StandoutScience
Stereoselective amino acid synthesis by photobiocatalytic oxidative coupling
2024 StandoutNature
2 intermediate papers

Works of Heather K. Webb being referenced

Idelalisib, an inhibitor of phosphatidylinositol 3-kinase p110δ, for relapsed/refractory chronic lymphocytic leukemia
2014 Standout
4-Chlorothreonine Is Substrate, Mechanistic Probe, and Mechanism-based Inactivator of Serine Hydroxymethyltransferase
1995

Author Peers

Author Last Decade Papers Cites
Heather K. Webb 676 329 720 607 23 1.7k
Rosa Santacroce 532 197 443 188 53 1.9k
Allard Kaptein 1094 29 536 446 39 2.2k
Aparna Venkatraman 919 122 254 234 31 2.0k
J P Le Couedic 435 81 395 196 22 1.6k
J. Greg Slatter 758 122 155 128 49 1.9k
Mark Catherwood 435 55 424 382 53 1.2k
Seiichiro Kamimura 394 220 76 663 45 1.6k
Ina Koch 498 55 127 153 33 1.6k
Glen S. Germain 980 78 163 162 30 1.6k
Nancy Lewis Baenziger 751 255 217 55 30 2.0k

All Works

Loading papers...

Rankless by CCL
2026